Not Yet RecruitingPhase 2Phase 3ACTRN12606000024549

Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis

Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis of the knees and/or hips


Sponsor

Healtheries of New Zealand Ltd

Enrollment

100 participants

Start Date

Jan 30, 2006

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 75 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis. You may be eligible if you are people aged 18 to 75 with total womac score of >30 at baseline-x-ray and clinical evidence of osteoarthritis of the knees and/or hips. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Biolane for a period of 18 weeks

Biolane for a period of 18 weeks


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000024549